NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $739.68 million as of January 21, 2026. Its market cap has increased by 24,556.10% in one year.

Market Cap

739.68M

Enterprise Value

738.34M

1-Year Change

24,556.10%

Ranking

#2804

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has increased from $76.50M to $739.68M, an increase of 866.91%. That is a compound annual growth rate of 13.24%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2026	739.70M	4.08%
Dec 31, 2025	710.70M	24,406.90%
Dec 31, 2024	2.90M	123.08%
Dec 29, 2023	1.30M	-63.89%
Dec 30, 2022	3.60M	-78.70%
Dec 31, 2021	16.90M	-41.92%
Dec 31, 2020	29.10M	62.57%
Dec 31, 2019	17.90M	35.61%
Dec 31, 2018	13.20M	-77.70%
Dec 29, 2017	59.20M	18.64%
Dec 30, 2016	49.90M	612.86%
Dec 31, 2015	7.00M	-78.46%
Dec 31, 2014	32.50M	-32.85%
Dec 31, 2013	48.40M	43.62%
Dec 31, 2012	33.70M	-11.32%
Dec 30, 2011	38.00M	-1.81%
Dec 31, 2010	38.70M	-19.21%
Dec 31, 2009	47.90M	118.72%
Dec 31, 2008	21.90M	-72.59%
Dec 31, 2007	79.90M	4.44%
Oct 26, 2007	76.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Valneva SE	881.01M
Omeros	869.24M
Bright Minds Biosciences	859.74M
Vir Biotechnology	834.75M
YD Bio	830.48M
Geron	829.86M
Arbutus Biopharma	808.72M
MiMedx Group	798.27M

Market Cap Rankings